Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-20

Clinical Trial Update: GI Alpha-Gal Study [NA]

View source ↗

Summary

UNC Chapel Hill is recruiting for a GI Alpha-Gal Study. The study investigates Alpha-gal syndrome and irritable bowel syndrome, with symptoms including diarrhea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alpha-Gal Syndrome, Irritable Bowel Syndrome | NA | Status: RECRUITING